StemCellPatents.com Newsletter

Hello ,

Last week a patent (#7,524,500) was issued covering the crosslinking of CD163 as a method of activating stem cells.  CD163 is a scavenger receptor primarily known for its expression on macrophages.

Another relevant patent from last week was #7,524,490 which covers the use of clusterin transfected bone marrow stem cells for suppressing apoptosis in the heart.  Clusterin is a protein involved in control of cell death and cell communications. 

In the news, a paper was published describing rejection of allogeneic embryonic stem cell derived dopaminergic cells in an allogeneic system.

Method of stimulating stem cells     Patent Number: 7,524,500 Assignee | Inventor Methods of expanding stem cells are well-known in the art.  For example, #7,423,029 teaches the use of heterocyclic trialkyl ammonium-containing compounds for stimulation of bone marrow stem cells.  #7,135,459 covers use of FGF homologues for expansion of neural and...[Read More] Ask a question OR leave your comments.

Allogeneic rejection of embryonic stem cells Monday May 4th, 2009 @ 02:15:43 EST Nara, Japan - Seeing stem cell therapy as sources of cytokines or angiogenic factors allows the possibility that the stem cell will eventually be rejected but the therapeutic effect will remain.  For example, mesenchymal stem cells are known to secrete various immune modulatory factors, such as soluble [Read More] Ask a question OR leave your comments. Read more StemCellPatents.com News

Media Partnerships (NEW)

RECENTLY ADDED PATENTS     Mammary stem cell marker (7,563,619) Assignee | Inventor | Ask a question OR leave your comments     Soft tissue repair and regeneration using postpartum-derived cells (7,560,276) Assignee | Inventor | Ask a question OR leave your comments     Compositions and methods for generating skin (7,560,275) Assignee | Inventor | Ask a question OR leave your comments     Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease (7,560,102) Assignee | Inventor | Ask a question OR leave your comments     Human cord blood derived unrestricted somatic stem cells (USSC) (7,560,280) Assignee | Inventor | Ask a question OR leave your comments     Human cord blood derived unrestricted somatic stem cells (USSC) (7,556,801) Assignee | Inventor | Ask a question OR leave your comments     Dedifferentiated, programmable stem cells of monocytic origin, and their production and use (7,553,663) Assignee | Inventor | Ask a question OR leave your comments     Stromal antigen-presenting cells and use thereof (7,553,661) Assignee | Inventor | Ask a question OR leave your comments     Directed in vitro differentiation of marrow stromal cells into neural cell progenitors (7,547,545) Assignee | Inventor | Ask a question OR leave your comments     Progenitor cells from wharton's jelly of human umbilical cord (7,547,546) Assignee | Inventor | Ask a question OR leave your comments     View all 1436 Stem Cell Patents on StemCellPatents.com

LATEST NEWS     Leptin Blocks T Regulatory Cell Expansion August 23rd, 2009     Mechanism of Multiple Sclerosis Stem Cell Therapy July 24th, 2009 : 2 Comments     Lithium for Treatment of Multiple Sclerosis July 15th, 2009     Treatment of Degenerative Disc Disease by Bone Marrow Stem Cells July 9th, 2009 : 2 Comments     Apoptotic Cells Secrete Angiogenic Factors June 27th, 2009     Read more news on StemCellPatents.com

LATEST JOBS POSTS     View the StemCellPatents.com Job Board

Thanks again for your help in supporting StemCellPatents.com.

Media Partnerships (NEW)

(BETA)